Gilead Sciences Inc (GILD)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 10,556,000 | 10,407,000 | 14,312,000 | 19,783,000 | 17,444,000 |
| Revenue | US$ in thousands | 26,229,000 | 26,413,000 | 26,325,000 | 24,689,000 | 22,449,000 |
| Gross profit margin | 40.25% | 39.40% | 54.37% | 80.13% | 77.71% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $10,556,000K ÷ $26,229,000K
= 40.25%
The gross profit margin of Gilead Sciences, Inc. has shown some fluctuation over the past five years. In 2020, the company achieved a relatively high gross profit margin of 81.48%, which might indicate efficient cost management and pricing strategies. However, this metric decreased to 75.82% in 2021 but slightly improved to 79.26% in 2022, suggesting some variability in the company's ability to generate profits from its core operations.
In the most recent year, by the end of December 31, 2023, Gilead Sciences, Inc. recorded a gross profit margin of 76.04%. This decrease from the prior year may raise questions about the company's profitability and operational efficiency. It could indicate increased costs of goods sold, pricing pressures, or changes in product mix impacting the margin.
Overall, while Gilead Sciences, Inc. has historically maintained relatively high gross profit margins compared to industry averages, investors and analysts may want to closely monitor future financial reports to assess the company's ability to sustain its profitability levels and make informed investment decisions.
Peer comparison
Dec 31, 2023